Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report

被引：7
|
作者：
Nalbant, Selim [1 ]
Ozyurt, Mustafa [2 ]
Yildirim, Murat [3 ]
Kuskucu, Mesih [4 ]
机构：
[1] Maltepe Univ, Sch Med, Dept Internal Med, Istanbul, Turkey
[2] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Microbiol, Istanbul, Turkey
[3] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Internal Med, Istanbul, Turkey
[4] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Orthoped Surg, Istanbul, Turkey
来源：
RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 09期
关键词：
Rheumatoid arthritis; Anti-TNF agents; Knee joint; Tuberculosis; RISK; ANTAGONISTS; BLOCKERS; AGENTS;
D O I：
10.1007/s00296-011-2119-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Tuberculosis infection (TB) is one of the most important problems for the rheumatoid arthritis (RA) patients treated with anti-TNF agents. Pulmonary tuberculosis is the most common clinic form of the TB in these patients. However, tuberculosis arthritis is very rare. We present here a 72-year-old Caucasian woman with seropositive RA, treated with etanercept/adalimumab for the last 2 years, who presented with resistant knee pain and joint effusion. We believe that this treatment caused the tuberculosis in this patient, which is the most worried complication. Interestingly, tuberculosis was in the knee joint at this time.
引用
收藏
页码：2863 / 2866
页数：4
相关论文
共 50 条
  • [1] Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report
    Selim Nalbant
    Mustafa Özyurt
    Murat Yıldırım
    Mesih Kuskucu
    [J]. Rheumatology International, 2012, 32 : 2863 - 2866
  • [2] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    [J]. ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [3] Weight Gain in Seropositive Rheumatoid Arthritis Patients Treated With Anti-tumor Necrosis Factor (TNF) Therapy
    Alsulaim, Toka M.
    Almulla, Maryah H.
    Alotaibi, Najla S.
    AlQudari, Elham A.
    Alzahrani, Khalid A.
    Nori, Rawad M.
    Makkawy, Mosaab A.
    Alhamzi, Hanan A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [4] Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor
    Hamann, Philip
    Holland, Richard
    Hyrich, Kimme
    Pauling, John D.
    Shaddick, Gavin
    Nightingale, Alison
    McHugh, Neil
    [J]. ARTHRITIS CARE & RESEARCH, 2017, 69 (06) : 783 - 793
  • [5] Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
    Daniel, Rodney S.
    Bourne, Rae L.
    Simpson, Annie N.
    O'Rourke, Kenneth S.
    Bolster, Marcy B.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2009, 1 (02) : 81 - 89
  • [6] Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
    Haerter, G
    Manfras, BJ
    de Jong-Hesse, Y
    Wilts, H
    Mertens, T
    Kern, P
    Schmitt, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : E88 - E94
  • [7] Two episodes of digital vasculitis in a patient with rheumatoid arthritis (RA) treated with anti-tumor necrosis factor-α (TNF-α): case report
    Mohammad, Aladdin
    Noltorp, Sven
    [J]. APMIS, 2009, 117 : 110 - 110
  • [8] The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis
    Tikiz, Hakan
    Arslan, Oezlem
    Pirildar, Timur
    Tikiz, Canan
    Bayindir, Petek
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (02): : 98 - 103
  • [9] Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis
    Favalli, EG
    Arreghini, M
    Arnoldi, C
    Panni, B
    Marchesoni, A
    Tosi, S
    Pontikaki, I
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 301 - 302
  • [10] Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
    Feldmann, M
    Brennan, F
    Paleolog, E
    Taylor, P
    Maini, RN
    [J]. EUROPEAN CYTOKINE NETWORK, 1997, 8 (03) : 297 - 300
12345